Aptose Biosciences Ownership | Who Owns Aptose Biosciences?


OverviewForecastFinancialsChartTranscripts

Aptose Biosciences Ownership Summary


Aptose Biosciences is owned by 0.11% institutional investors, 6.10% insiders, and 93.79% retail investors. Nations financial group inc, /ia/ /adv is the largest institutional shareholder, holding 0.11% of APTO shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Aptose Biosciences shares.

APTO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAptose Biosciences0.11%6.10%93.79%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nations financial group inc, /ia/ /adv19.50K0.11%$4.39K
Caldwell sutter capital92.000.00%$21.00
Doheny asset management /ca---
Annandale capital---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nations financial group inc, /ia/ /adv19.50K0.00%$4.39K
Caldwell sutter capital92.00-$21.00
Doheny asset management /ca---
Annandale capital---

Top Buyers

HolderShares% AssetsChange
Nations financial group inc, /ia/ /adv19.50K0.00%19.50K
Caldwell sutter capital92.00--
Annandale capital---26.67K
Doheny asset management /ca---50.55K

Top Sellers

HolderShares% AssetsChange
Doheny asset management /ca---50.55K
Annandale capital---26.67K
Caldwell sutter capital92.00--
Nations financial group inc, /ia/ /adv19.50K0.00%19.50K

New Positions

HolderShares% AssetsChangeValue
Nations financial group inc, /ia/ /adv19.50K0.00%19.50K$4.39K

Sold Out

HolderChange
Annandale capital-26.67K
Doheny asset management /ca-50.55K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242100.00%19,59221195.65%-42591300.00%1---
Sep 30, 20241-50.00%92-99.82%-0.34%--100.00%--
Jun 30, 20242-50,64289.26%-245.77%1---100.00%
Mar 31, 20242-26,758-64.21%-29.90%--1-
Dec 31, 20232-74,758-10.36%--100.00%--

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index2.16K0.01%-
Dimensional Canadian Small Company767.000.00%-
DFA International Small Company I741.000.00%-
DFA Global Small Company Institutional1.00--

Recent Insider Transactions


DateNameRoleActivityValue
Nov 25, 2024Rice William G. Chair, President & CEOBuy$12.50K
Nov 25, 2024Rice William G. Chair, President & CEOBuy$20.00K
Sep 22, 2023Seizinger Bernd R.-Buy$53.38K
Sep 19, 2022Rice William G. Chair, President & CEOBuy$6.83K
Jun 06, 2022Rice William G. Chair, President & CEOBuy$9.68K

Insider Transactions Trends


DateBuySell
2027 Q2--
2024 Q1--
2023 Q31-
2023 Q1--
2022 Q31-

APTO Ownership FAQ


Who Owns Aptose Biosciences?

Aptose Biosciences shareholders are primarily institutional investors at 0.11%, followed by 6.10% insiders and 93.79% retail investors. The average institutional ownership in Aptose Biosciences's industry, Biotech Stocks , is 68.48%, which Aptose Biosciences falls below.

Who owns the most shares of Aptose Biosciences?

Aptose Biosciences’s largest shareholders are Nations financial group inc, /ia/ /adv (19.5K shares, 0.11%), Caldwell sutter capital (92 shares, 0.00%), and Doheny asset management /ca (0 shares, 0%). Together, they hold 0.11% of Aptose Biosciences’s total shares outstanding.

Does Blackrock own Aptose Biosciences?

BlackRock is not among the top 10 institutional shareholders of Aptose Biosciences.

Who is Aptose Biosciences’s biggest shareholder by percentage of total assets invested?

Nations financial group inc, /ia/ /adv is Aptose Biosciences’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 19.5K Aptose Biosciences shares, valued at 4.39K$.

Who is the top mutual fund holder of Aptose Biosciences shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Aptose Biosciences shares, with 0.01% of its total shares outstanding invested in 2.16K Aptose Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools